Back to search
FDAFDA · Food and drugs·Recall number Z-0832-2013

CareFusion SmartSite Gravity Blood Set Model 42082E. Used to administer blood and blood products through a needle or catheter inserted into the patient's artery or vein.

Published February 27, 2013 · Recall initiated: December 20, 2012

Summary

FDA records medical device Class II recall Z-0832-2013, published February 27, 2013 and initiated December 20, 2012. Recalling firm: Carefusion 303 Inc; Status: Terminated; Reported quantity: 5,050 units; Lot: Lot number 12055225. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CareFusion is recalling the SmartSite® Gravity Blood Set as a result of a potential for separation at the connection of the drip chamber and tubing . The separation may be observed at priming or observed during use. If a separation between the drip chamber and tubing occurs, this could cause a delay in treatment.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Carefusion 303 Inc
Distributor
Nationwide Distribution including the states of AK, CA, CO, IL, MO, NV, NY, TX and UT.
Lot
Lot number 12055225
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was CareFusion SmartSite Gravity Blood Set Model 42082E. Used to administer blood and blood products through a needle or catheter inserted into the patient's artery or vein. recalled?

Yes. FDA published recall Z-0832-2013 on February 27, 2013. Reported hazard: CareFusion is recalling the SmartSite® Gravity Blood Set as a result of a potential for separation at the connection of the drip chamber and tubing . The separation may be observed at priming or observed during use. If a separation between the drip chamber and tubing occurs, this could cause a delay in treatment.

What should I do if I have this product?

Voluntary: Firm initiated · Letter